120 related articles for article (PubMed ID: 37567436)
1. ΔNp63 overexpression promotes oral cancer cell migration through hyperactivated Activin A signaling.
Mundhe D; Mishra R; Basu S; Dalal S; Kumar S; Teni T
Exp Cell Res; 2023 Oct; 431(1):113739. PubMed ID: 37567436
[TBL] [Abstract][Full Text] [Related]
2. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma.
Ervolino De Oliveira C; Dourado MR; Sawazaki-Calone Í; Costa De Medeiros M; Rossa Júnior C; De Karla Cervigne N; Esquiche León J; Lambert D; Salo T; Graner E; Coletta RD
Int J Oncol; 2020 Jul; 57(1):364-376. PubMed ID: 32377747
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
4. Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program.
Vasilaki E; Morikawa M; Koinuma D; Mizutani A; Hirano Y; Ehata S; Sundqvist A; Kawasaki N; Cedervall J; Olsson AK; Aburatani H; Moustakas A; Miyazono K; Heldin CH
Sci Signal; 2016 Aug; 9(442):ra84. PubMed ID: 27555661
[TBL] [Abstract][Full Text] [Related]
5. TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.
Sundqvist A; Vasilaki E; Voytyuk O; Bai Y; Morikawa M; Moustakas A; Miyazono K; Heldin CH; Ten Dijke P; van Dam H
Oncogene; 2020 May; 39(22):4436-4449. PubMed ID: 32350443
[TBL] [Abstract][Full Text] [Related]
6. Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells.
Tsai CN; Tsai CL; Yi JS; Kao HK; Huang Y; Wang CI; Lee YS; Chang KP
Sci Rep; 2019 Mar; 9(1):5197. PubMed ID: 30914776
[TBL] [Abstract][Full Text] [Related]
7. Concomitant overexpression of Activin A and p63 is associated with poor outcome in oral cancer patients.
Mundhe D; Waghole R; Pawar S; Mishra R; Shetty A; Gera P; Kannan S; Teni T
J Oral Pathol Med; 2020 Oct; 49(9):876-885. PubMed ID: 32512627
[TBL] [Abstract][Full Text] [Related]
8. ΔNp63 promotes UM‑UC‑3 cell invasiveness and migration through claudin‑1 in vitro.
Jing P; Zou J; Zhang J; Jiang X
Mol Med Rep; 2013 Mar; 7(3):1026-30. PubMed ID: 23313968
[TBL] [Abstract][Full Text] [Related]
9. ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2.
Ram Kumar RM; Betz MM; Robl B; Born W; Fuchs B
BMC Cancer; 2014 Aug; 14():559. PubMed ID: 25085524
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression.
Chang KP; Kao HK; Liang Y; Cheng MH; Chang YL; Liu SC; Lin YC; Ko TY; Lee YS; Tsai CL; Wang TH; Hao SP; Tsai CN
Ann Surg Oncol; 2010 Jul; 17(7):1945-56. PubMed ID: 20309641
[TBL] [Abstract][Full Text] [Related]
11. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
[TBL] [Abstract][Full Text] [Related]
12. p63-Mediated activation of the β-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis.
Lee KB; Ye S; Park MH; Park BH; Lee JS; Kim SM
Cancer Lett; 2014 Oct; 353(1):124-32. PubMed ID: 25045846
[TBL] [Abstract][Full Text] [Related]
13. Metformin and 4SC-202 synergistically promote intrinsic cell apoptosis by accelerating ΔNp63 ubiquitination and degradation in oral squamous cell carcinoma.
He Y; Tai S; Deng M; Fan Z; Ping F; He L; Zhang C; Huang Y; Cheng B; Xia J
Cancer Med; 2019 Jul; 8(7):3479-3490. PubMed ID: 31025540
[TBL] [Abstract][Full Text] [Related]
14. Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation.
Wu HH; Wang B; Armstrong SR; Abuetabh Y; Leng S; Roa WHY; Atfi A; Marchese A; Wilson B; Sergi C; Flores ER; Eisenstat DD; Leng RP
Nucleic Acids Res; 2021 Mar; 49(5):2740-2758. PubMed ID: 33619536
[TBL] [Abstract][Full Text] [Related]
15. p63 regulates growth of esophageal squamous carcinoma cells via the Akt signaling pathway.
Ye S; Lee KB; Park MH; Lee JS; Kim SM
Int J Oncol; 2014 Jun; 44(6):2153-9. PubMed ID: 24718831
[TBL] [Abstract][Full Text] [Related]
16. Activin B promotes endometrial cancer cell migration by down-regulating E-cadherin via SMAD-independent MEK-ERK1/2-SNAIL signaling.
Xiong S; Klausen C; Cheng JC; Leung PC
Oncotarget; 2016 Jun; 7(26):40060-40072. PubMed ID: 27223076
[TBL] [Abstract][Full Text] [Related]
17. DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.
Danilov AV; Neupane D; Nagaraja AS; Feofanova EV; Humphries LA; DiRenzo J; Korc M
PLoS One; 2011; 6(10):e26815. PubMed ID: 22053213
[TBL] [Abstract][Full Text] [Related]
18. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.
Buckley NE; D'Costa Z; Kaminska M; Mullan PB
Cell Death Dis; 2014 Feb; 5(2):e1070. PubMed ID: 24556685
[TBL] [Abstract][Full Text] [Related]
19. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma.
Cam M; Gardner HL; Roberts RD; Fenger JM; Guttridge DC; London CA; Cam H
Oncotarget; 2016 Jul; 7(30):48533-48546. PubMed ID: 27391430
[TBL] [Abstract][Full Text] [Related]
20. Activin A promotes ovarian cancer cell migration by suppressing E-cadherin expression.
Yi Y; Cheng JC; Klausen C; Leung PCK
Exp Cell Res; 2019 Sep; 382(2):111471. PubMed ID: 31229504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
